Nano-X Imaging Ltd. NNOX
Last close
—
Market cap
—
52-week range
— - —
No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS-1.16
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.0M | $11.3M | $9.9M | $8.6M | $1.3M | — | — | — | — |
| Cost of revenue | $25.8M | $21.9M | $16.5M | $15.5M | $2.8M | — | — | — | — |
| Gross profit | -$12.8M | -$10.6M | -$6.6M | -$6.9M | -$1.5M | — | — | — | — |
| R&D | $19.2M | $20.2M | $26.0M | $26.5M | $17.1M | $9.2M | $2.7M | $672.0K | — |
| SG&A | $21.6M | $22.5M | $24.3M | $41.3M | $34.7M | $22.3M | $18.3M | $1.0M | — |
| Total operating expenses | $65.4M | $46.1M | $56.0M | $110.8M | $60.0M | $43.9M | $22.6M | $1.9M | — |
| Operating income | -$78.2M | -$56.7M | -$62.6M | -$117.7M | -$61.6M | -$43.9M | -$22.6M | -$1.9M | — |
| Pre-tax income | -$76.8M | -$53.9M | -$61.1M | -$116.9M | -$61.8M | -$43.8M | -$22.6M | — | — |
| Income tax | $1.8M | $358.0K | $339.0K | $3.7M | $48.0K | — | — | — | — |
| Net income | -$75.0M | -$53.5M | -$60.8M | -$113.2M | -$61.8M | -$43.8M | -$22.6M | -$1.9M | — |
| EPS, basic | -1.16 | -0.91 | -1.08 | -2.17 | -1.28 | -1.23 | -0.90 | — | — |
| EPS, diluted | -1.16 | -0.91 | -1.08 | -2.17 | -1.28 | -1.23 | -0.90 | -0.09 | — |
| Shares, diluted (wtd. avg.) | 64,790 | 58,673 | 56,368 | 52.2M | 48,216 | 35,654 | 25,181 | — | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $49.2M | $39.3M | $56.4M | $38.5M | $66.6M | $213.5M | $8.2M | $5.0K | $65.0K |
| Short-term investments | — | $18.4M | $26.0M | $39.2M | $22.1M | — | — | — | — |
| Inventory | $3.1M | $1.5M | $2.4M | — | $116.0K | — | — | — | — |
| Total current assets | $66.8M | $78.7M | $88.6M | $82.5M | $94.9M | $219.8M | $9.6M | — | — |
| Property, plant and equipment | $29.7M | $45.4M | $42.3M | $43.5M | $37.4M | $14.0M | $228.0K | — | — |
| Goodwill | $316.0K | — | — | $7.4M | $58.3M | — | — | — | — |
| Other intangibles | $59.9M | $70.0M | $80.6M | $91.2M | $101.8M | — | — | — | — |
| Total assets | $162.2M | $210.0M | $218.6M | $253.9M | $363.2M | $236.1M | $11.9M | — | — |
| Accounts payable | $2.9M | $2.2M | $3.3M | $3.6M | $3.1M | $435.0K | $475.0K | — | — |
| Short-term debt | $3.1M | $3.1M | $3.5M | — | $145.0K | — | — | — | — |
| Total current liabilities | $16.9M | $14.0M | $15.5M | $25.1M | $52.8M | $4.5M | $20.3M | — | — |
| Long-term debt | — | — | — | $3.5M | $3.8M | — | — | — | — |
| Total liabilities | $22.4M | $20.9M | $23.1M | $37.3M | $71.0M | $5.4M | $20.6M | — | — |
| Retained earnings | -$448.8M | -$373.7M | -$320.2M | -$259.5M | -$146.2M | -$84.4M | -$40.6M | — | — |
| Total equity | $139.7M | $189.1M | $195.5M | $216.7M | $292.1M | $230.7M | -$8.8M | -$6.4M | -$8.3M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$40.8M | -$36.6M | -$44.8M | -$43.4M | -$38.1M | -$21.6M | -$5.5M | -$3.7M | — |
| Depreciation and amortisation | $1.2M | $1.1M | $1.2M | $905.0K | $524.0K | $208.0K | $53.0K | $35.0K | — |
| Stock-based compensation | $4.2M | $7.3M | $6.8M | $18.6M | $18.8M | $24.8M | $16.2M | $115.0K | — |
| Capital expenditure | $4.2M | $2.8M | $3.3M | $7.2M | $23.2M | $13.9M | $125.0K | $73.0K | — |
| Investing cash flow | $29.4M | -$20.1M | $35.4M | $14.6M | -$116.3M | -$13.9M | -$125.0K | -$73.0K | — |
| Financing cash flow | $21.4M | $39.5M | $27.3M | $804.0K | $7.4M | $241.0M | $13.9M | $3.7M | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001213900-26-050191.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $1.3M | $8.6M | $9.9M | $11.3M | $13.0M |
| Gross profit | — | — | — | — | -$1.5M | -$6.9M | -$6.6M | -$10.6M | -$12.8M |
| Net income | — | -$1.9M | -$22.6M | -$43.8M | -$61.8M | -$113.2M | -$60.8M | -$53.5M | -$75.0M |
Others in SIC 3844
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| GEHC | GE HealthCare Technologies Inc. | $32.74B | 15.8x | 4.8% |
| BFLY | Butterfly Network, Inc. | $1.75B | — | 19.0% |
| MBAI | Check-Cap Ltd | — | — | — |
| PHG | KONINKLIJKE PHILIPS NV | — | — | — |